Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04374630
Title Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian (PROFECTA-II)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Laekna Limited
Indications

ovarian clear cell carcinoma

ovarian serous carcinoma

endometrioid ovary carcinoma

peritoneum cancer

fallopian tube cancer

Therapies

Afuresertib + Paclitaxel

Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.